 CANTEL MEDICAL CORP. NYSE:CMD announced an estimated revenue range for the companys fiscal fourth quarter, which ended July 31st, 2020. Revenue for the fourth quarter is estimated at 230 - 235 million, a decrease of approximately 2 sequentially vs. the prior quarter, and down approximately 19 vs. the prior year on an organic basis. 